Journal of Clinical Endocrinology & Metabolism

Article	Citations
Response to Letter to the Editor From Jagannath and Mayilvaganan: “FCH-PET/CT in Primary Hyperparathyroidism With Discordant/Negative MIBI Scintigraphy and Ultrasonography”	384
Response to Letter to the Editor From de Zegher and Ibáñez: “Metformin and Combined Oral Contraceptive Pills in the Management of Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis”	215
A Step Toward Disentangling the Complex Relationship Between Vitamin D and Kidney Function	186
Turner's Syndrome, Glucagon-like Peptide 1, and Glucose-dependent Insulinotropic Polypeptide Agents: Silver Bullets?	179
Novel Lipidomic Signature Associated With Metabolic Risk in Women With and Without Polycystic Ovary Syndrome	160
Resting Energy Expenditure and Cold-induced Thermogenesis in Patients With Overt Hyperthyroidism	143
Duodenal Mucosal Expression of COVID-19-Related Genes in Health, Diabetic Gastroenteropathy, and Functional Dyspepsia	133
Insulin Sensitivity and Insulin Secretion in Adults With Friedreich's Ataxia: The Role of Skeletal Muscle	121
Suppression of Endogenous Insulin Secretion by Euglycemic Hyperinsulinemia	120
Correction to: “Associations of Serum Vitamin B6 Status and Catabolism With All-Cause Mortality in Patients With T2DM”	116
Correction to: “Critical Approach to Hypothyroid Patients With Persistent Symptoms”	110
Correction to “Recent Insights into Noncoding RNAs in Primary Ovarian Insufficiency: Focus on Mechanisms and Treatments”	105
Correction to “Gut Microbiome Associated With Graves Disease and Graves Orbitopathy: The INDIGO Multicenter European Study”	96
Effect of Liraglutide Treatment on Whole-body Glucose Fluxes in C-peptide–Positive Type 1 Diabetes During Hypoglycemia	91
Response to Letter to the Editor From Sukor and Kamaruddin: “Higher Risk of Incident Hyperthyroidism in Patients With Atrial Fibrillation”	82
Novel Associations of Empagliflozin on the Gut Microbiome and Metabolome in Type 2 Diabetes	82
Mapping the Cord Blood Transcriptome of Pregnancies Affected by Early Maternal Anemia to Identify Signatures of Fetal Programming	80
Correction to: “Contralateral Suppression in Adrenal Venous Sampling Predicts Clinical and Biochemical Outcome in Primary Aldosteronism”	78
Effect of Anamorelin, a Ghrelin Receptor Agonist, on Muscle and Bone in Adults With Osteosarcopenia	76
Influence of Maternal Exercise on Glucose and Lipid Metabolism in Offspring Stem Cells: ENHANCED by Mom	74
GLP-1 Receptor Blockade Reduces Stimulated Insulin Secretion in Fasted Subjects With Low Circulating GLP-1	69
Ectopic Cervical Thymoma in a Patient Diagnosed With Graves Disease: A Systematic Literature Review	68
Correction to: “Vitamin D Status, Vitamin D Receptor Polymorphisms, and Risk of Type 2 Diabetes: A Prospective Cohort Study”	66
Distinct Lipidomic Signatures in People Living With HIV: Combined Analysis of ACTG 5260s and MACS/WIHS	65
Hemoglobin Glycation Index: A Novel Risk Factor for Incident Chronic Kidney Disease in an Apparently Healthy Population	63

Growth Patterns of Children With Short Stature in Adulthood According to Auxological Status and Maturity at Birth	62
Antiatherosclerotic Effects of Sodium-Glucose Cotransporter 2 Inhibitors: An Underrecognized Piece of the Big Puzzle?	61
Approach to the Patient Considering Long-term Antithyroid Drug Therapy for Graves’ Disease	61
Impact of Newborn Screening on Adult Height in Patients With Congenital Adrenal Hyperplasia (CAH)	60
Higher Free Triiodothyronine Is Associated With Higher HDL Particle Concentration and Smaller HDL Particle Size	60
Insights on Improving Health Insurance Literacy in Diabetes	59
Transitions in Metabolic Health Status and Obesity Over Time and Risk of Diabetes: The Dongfeng–Tongji Cohort Study	59
Association of Age at Menarche With Inflammation and Glucose Metabolism Biomarkers in US Adult Women: NHANES 1999-2018	59
Glycemic, Cardiorenal, and Weight Implications on Noninsulin Pharmacotherapy for the Management of Type 2 Diabetes	59
Polycystic Ovary Syndrome Physiologic Pathways Implicated Through Clustering of Genetic Loci	58
GCM2Variants in Familial and Multiglandular Primary Hyperparathyroidism	58
Depressive Syndromes in Men With Hypogonadism in the TRAVERSE Trial: Response to Testosterone-Replacement Therapy	57
Prospective Multicenter Registry–Based Study on Thyroid Storm: The Guidelines for Management From Japan Are Useful	57
Approach to the Patient: Management of Parathyroid Diseases Across Pregnancy	56
Changes in Collagen Type I C-Telopeptide and Procollagen Type I N-Terminal Propeptide During the Menopause Transition	56
Denosumab After Teriparatide in Premenopausal Women With Idiopathic Osteoporosis	55
Association of Circulating Very Long-Chain Saturated Fatty Acids With Cardiovascular Mortality in NHANES 2003-2004, 2011-2012	55
Circulating miRNAs Respond to Denosumab Treatment After 2 Years in Postmenopausal Women With Osteoporosis—the MiDeTe study	53
The Association of Adiposity and RAAS With Incident Diabetes in African Americans: The Jackson Heart Study	52
Long-read Amplicon Sequencing of the CYP21A2 in 48 Thai Patients With Steroid 21-Hydroxylase Deficiency	52
Approach to the Patient with Primary Aldosteronism: Role of Molecular Imaging	51
Remnant Cholesterol Is Associated With Gestational Diabetes Mellitus: A Cohort Study	51
Effects of Simulated High Altitude on Blood Glucose Levels During Exercise in Individuals With Type 1 Diabetes	50
Testosterone Therapy With Subcutaneous Injections: A Safe, Practical, and Reasonable Option	50
Signs of a Glucose- and Insulin-Independent Gut-Bone Axis and Aberrant Bone Homeostasis in Type 1 Diabetes	49
Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman	48
Clinical use of Molecular Data in Thyroid Nodules and Cancer	48
Type 2 Diabetes Remission: Achieving Calorie Restriction and Weight Loss by Any Which Way?	47
Branched-Chain Amino Acids and Their Interactions With Lipid Metabolites for Increased Risk of Gestational Diabetes	47
Acute Effects of Kisspeptin Administration on Bone Metabolism in Healthy Men	46
Demographic, Healthcare Access, and Dietary Factors Associated With Thyroid Hormone Treatments for Hypothyroidism	46
Dehydroepiandrosterone Sulfate and Mortality in Middle-Aged and Older Men and Women—A J-shaped Relationship	44
Correction to: “Metabolic Profiles of Pregnancy With Polycystic Ovary Syndrome: Insights into Maternal-Fetal Metabolic Communication”	43
Differences Between GH- and PRL-Cosecreting and GH-Secreting Pituitary Adenomas: a Series of 604 Cases	43
Signs of Potential Androgen Excess Across the Lifespan in a US-based Digital Cohort Study	43
Gender-Affirming Treatment and Employment Rate in 3812 Danish Transgender Persons and 38 120 Controls	43
Response to Letter to the Editor from Hasebe and Su: “Adrenalectomy Reduces the Risk of Vertebral Fractures in Patients With Mild Autonomous Cortisol Secretion”	42
Lack of GNAS Remethylation During Oogenesis May Be a Cause of Sporadic Pseudohypoparathyroidism Type Ib	42
Characterizing 24-Hour Skeletal Muscle Gene Expression Alongside Metabolic and Endocrine Responses Under Diurnal Conditions	42
Tracking and Cumulative Lifetime Exposure to IGF-I in 6459 Healthy Individuals and in SGA Children Treated With GH	42
Serum 25-Hydroxyvitamin D is Associated With Bone Microarchitecture and Strength in a Multiracial Cohort of Young Adults	42
Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia	41
Sequential Therapy for the Long-Term Treatment of Postmenopausal Osteoporosis	41
Approach to the Patient: Differential Diagnosis of Cystic Sellar Lesions	41
High Incidence of Diabetes Mellitus After Distal Pancreatectomy and Its Predictors: A Long-term Follow-up Study	41
Association of Thyroid Dysfunction in Individuals ≥ 65 Years of Age With Subclinical Cardiac Abnormalities	41
Effects of Maternal Exercise Modes on Glucose and Lipid Metabolism in Offspring Stem Cells	41
Circulating Inflammatory Cytokines and Female Reproductive Diseases: A Mendelian Randomization Analysis	41
Elevated TSH Level, TgAb, and Prior Use of Ramucirumab or TKIs as Risk Factors for Thyroid Dysfunction in PD-L1 Blockade	40
Mesenteric Visceral Lipectomy Improves Glucose Tolerance in Patients With Type 2 Diabetes: A Pilot Study	39

Clinical and Molecular Genetic Characteristics of Patients with Hereditary Hypophosphatemia	39
Association Between Urinary Phthalate Metabolites and Sarcopenia in US Adults From NHANES 2011-2018	39
Iodineminho Study: Iodine Supplementation and Prevalence of Iodine Deficiency In Pregnant Women	39
Stable Iodine Intake and Thyroid Screening Outcomes After the Fukushima Nuclear Disaster: An Observational Study	39
A Review of Hot Flash Management in Patients With Prostate Cancer	38
Approach to the Patient: Type 1 Diabetes Management With Exercise—Prepare, Perform, Stabilize, and Study	38
Parathyroidectomy Versus Calcimimetic: The Lower the PTH the Better?	38
Anti-Androgen and Aromatase Inhibitor Do Not Enhance Height in Children With CAH	38
Cognitive Function in Individuals with Chronic Hypoparathyroidism—A Prospective Observational Study	38
Proposed Denosumab Biosimilar SB16 vs Reference Denosumab in Postmenopausal Osteoporosis: Phase 3 Results Up to Month 12	38
Time to Increase Awareness and Diagnosis of Steatotic Liver Disease in Adolescents	38
Further Data Against the Use of Cyproterone Acetate in Gender-Affirming Hormone Therapy Regimens	38
The Diagnostic Value of 18F-FDG PET/CT Scan in Characterizing Adrenal Tumors	38
New Treatments for Acromegaly in Development	38
Correction to: “Reassuring Data on the Cardiovascular Risk in Adults With X-linked Hypophosphatemia Receiving Conventional Therapy”	37
Current Recommended Estrogen Dosing for Pubertal Induction in Turner Syndrome Results in Normal Uterine Growth	37
Correction to “Treatment of Hyperthyroidism Reduces Systemic Oxidative Stress, as Measured by Markers of RNA and DNA Damage”	37
Correction to “Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline”	37
Corrigendum to: Autonomous Cortisol Secretion Influences Psychopathological Symptoms in Patients With Primary Aldosteronism	36
Correction to: “Approach to the Patient: Reninoma”	36
A Phase I/II Trial of Sapanisertib in Advanced Anaplastic and Radioiodine Refractory Differentiated Thyroid Carcinoma	36
Response to Letter to the Editor from de Zegher and Ibáñez: “Rare Variation in LMNA Underlies Polycystic Ovary Syndrome (PCOS) in Two Independent Cohorts”	35
Three-Year Observation of Glucose Metabolism After Pancreaticoduodenectomy: A Single-Center Prospective Study in Japan	35
Total and Regional Fat-To-Muscle Mass Ratio in Relation to All-Cause and Cause-Specific Mortality in Men and Women	35
Reproductive Phenotypes in Men With Acquired or Congenital Hypogonadotropic Hypogonadism: A Comparative Study	35
RETRACTED AND REPLACED: Comparison of Cumulative Live Birth Rates Between Progestin and GnRH Analogues in Preimplantation Genetic Testing Cycles	35
Higher Plasma Levels of Endocannabinoids and Analogues Correlate With a Worse Cardiometabolic Profile in Young Adults	35
RBP4-based Multimarker Score: A Prognostic Tool for Adverse Cardiovascular Events in Acute Coronary Syndrome Patients	34
Changes in Serum Cytokines Throughout Pregnancy in Women With Polycystic Ovary Syndrome	34
METTL3-mediated RNA m6A Hypermethylation Promotes Tumorigenesis and GH Secretion of Pituitary Somatotroph Adenomas	34
Aging Men With Insufficient Vitamin D Have a Higher Mortality Risk: No Added Value of its Free Fractions or Active Form	34
Response to Letter to the Editor From Malozowski: “Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial”	34
Estimation of Glucose Absorption, Insulin Sensitivity, and Glucose Effectiveness From the Oral Glucose Tolerance Test	33
Associations of Serum 25(OH)D With Risk of Recurrent Cardiovascular Events in Individuals With Coronary Heart Disease	33
Response to Letter to the Editor From Han and Xu: “Association Between DPP4 Inhibitor Use and the Incidence of Cirrhosis, ESRD, and Some Cancers in Patients With Diabetes”	33
Letter to the Editor from Teede: “Clinical Practice Guidelines on the Diagnosis and Management of Polycystic Ovary Syndrome: A Systematic Review and Quality Assessment Study”	33
New Avenues for Pharmacological Management of Hyperphagia and Associated Behavioral Disorders in Prader-Willi Syndrome	33
Low-Quality Carbohydrate Intake Is Associated With a Higher Prevalence of Metabolic Syndrome: The AWHS Study	33
Does the Duration of Diabetes Matter When Evaluating the Risk of Heart Failure?	33
TUBB3 E410K Syndrome With Childhood-Onset Nonalcoholic Steatohepatitis	33
Response to Letter to the Editor from Hao and Xue: “Checkpoint Inhibitor-associated Autoimmune Diabetes Mellitus Is Characterized by C-Peptide Loss and Pancreatic Atrophy”	33
IGF-1/IGFBP-3 Serum Ratio as a Robust Measure to Determine GH Deficiency and Guide Human Recombinant GH Therapy	33
Letter to the Editor From Paolo Rossi and Rossitto: “Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism”	33
Letter to the Editor From Zhou et al.: “Association Between Body Weight and Telomere Length Is Predominantly Mediated Through C-Reactive Protein”	33
Plasma Polyamines as an Additional to Imaging Biomarker in MEN1 Patients With Duodenopancreatic Neuroendocrine Tumors	33
Letter to the Editor From Boucai and Tuttle: “BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-Associated Mortality Risk in Papillary Thyroid Cancer”	32
Serum DHEA and Testosterone Levels Associate Inversely With Coronary Artery Calcification in Elderly Men	32
Aggressive Subtypes of Papillary Microcarcinoma	32
Denosumab and Risk of Community-acquired Pneumonia: A Population-based Cohort Study	32
Taming Idiopathic Central Precocious Puberty: High Frequency of Imprinting Disorders in Familial Forms	32
Corrigendum to: Duodenal Mucosal Expression of COVID-19-related Genes in Health, Diabetes Gastroenteropathy and Functional Dyspepsia	32
Endogenous Glucose Production in Patients With Glycogen Storage Disease Type Ia Estimated by Oral D-[6,6-2H2]-glucose	32
Racial/Ethnic Inequities in Use of Diabetes Technologies Among Medicare Advantage Beneficiaries With Type 1 Diabetes	32
Correction to: “Adult Height Following Prepubertal Treatment With Antiandrogen, Aromatase Inhibitor, and Reduced Hydrocortisone in CAH”	31
Genetic Underpinnings of Fasting and Oral Glucose-stimulated Based Insulin Sensitivity Indices	31
Higher FSH Level Is Associated With Increased Risk of Incident Hip Fracture in Older Adults, Independent of Sex Hormones	31
Maternal and Fetal Genetic Variation in Vitamin D Metabolism and Umbilical Cord Blood 25-Hydroxyvitamin D	31
Approach to the Patient With Treatment-resistant Acromegaly	31
Precision Medicine in Acromegaly: The Potential of Multimodal Therapy	31
Mineralocorticoid Receptor and Aldosterone: Interaction Between NR3C2 Genetic Variants, Sex, and Age in a Mixed Cohort	31
What Is the Role for Pediatric Endocrinologists in the Management of Skeletal Dysplasias?	30
The Multifaceted Roles of Bone Marrow Adipocytes in Bone and Hematopoietic Homeostasis	30
Early Detection of Relapse by ctDNA Sequencing in a Patient with Metastatic Thymic Tumor and MEN1 Mosaicism	30
Current Practices in Monitoring Children and Adults With X-linked Hypophosphatemia: A Global Survey of Expert Experience	30
Associations of Age at Menopause With Postmenopausal Bone Mineral Density and Fracture Risk in Women	30
Risk of Type 2 Diabetes, MASLD and Cardiovascular Disease in People Living With Polycystic Ovary Syndrome	30
Low T3 Syndrome on Admission and Response to Nutritional Support in Malnourished Medical Inpatients	30
Exclusion Tests in Unilateral Primary Aldosteronism (ExcluPA) Study	29
Prevalence of Cortisol Cosecretion in Patients With Primary Aldosteronism: Role of Metanephrine in Adrenal Vein Sampling	29
Increased Prevalence of Germline Pathogenic CHEK2 Variants in Individuals With Pituitary Adenomas	29
Serum Klotho Modifies the Associations of 25-Hydroxy Vitamin D With All-Cause and Cardiovascular Mortality	29
Sleep Patterns, Plasma Metabolome, and Risk of Incident Type 2 Diabetes Mellitus	29
Triglyceride–Glucose Index and Risks of All-Cause and Cause-Specific Mortality in Young Adults	29
The Relationship Between Continuous Glucose Monitoring and OGTT in Youth and Young Adults With Cystic Fibrosis	29
Pancreatic Cancer Screening in New-onset and Deteriorating Diabetes: Preliminary Results From the PANDOME Study	29
Molecular Profiling of 50 734 Bethesda III-VI Thyroid Nodules by ThyroSeq v3: Implications for Personalized Management	29
Dyslipidemia is associated with increased NK cell cytotoxicity and autoimmunity in women with recurrent pregnancy losses	29
Metabolic Effects of Glucagon Stimulations in Type 1 Diabetes and Healthy Controls	29
Central Hypothyroidism is Frequent During Mitotane Therapy in Adrenocortical Cancer Patients: Prevalence and Timeline	29
Association Between Systemic Lupus Erythematosus and Primary Hypothyroidism: Evidence from Complementary Genetic Methods	29

New Therapies for Primary Hyperlipidemia	29
Dose-related Effects of Calcium to Enhance the Effects of L-tryptophan on Gut Hormones and Energy Intake in Obesity	28
New Insights on the Environment of Sex Steroids in Adipose Tissue of Postmenopausal Women at Hormone Therapy	28
Altered Microbiome Signature in Cushing's Syndrome Persists Beyond Remission	28
Outcomes and Therapeutic Strategies for Head-and-neck Paragangliomas Associated With Succinate Dehydrogenase Mutations	28
Correction to: Iron Overload in Functional Hyperandrogenism: In a Randomized Trial, Bloodletting Does Not Improve Metabolic Outcomes	28
Subtle Cognitive Impairments and Psychological Complaints in Patients With Prolactinoma Despite Biochemical Control	28
Long-term Efficacy and Safety of Pasireotide in Patients With Acromegaly: 14 Years of Single-Center Real-World Experience	28
Cognitive Risk Stratification Score in Middle-aged and Older Adults With Type 2 Diabetes: A Cross-Sectional Study	28
Effects of Rare Coding Variants in Severe Early-Onset Obesity Genes in the Population-Based UK Biobank Study	28
Genetic Variants Associated With Mineral Metabolism Traits in Chronic Kidney Disease	28
Correction to “Reduced Sensitivity to Thyroid Hormones Is Associated With High Remnant Cholesterol Levels in Chinese Euthyroid Adults”	28
The Impact of Acute Nutritional Interventions on the Plasma Proteome	28
Approach to the Patient: Low Testosterone Concentrations in Men With Obesity	28
Vitamin D Supplementation and Fractures in Adults: A Systematic Umbrella Review of Meta-Analyses of Controlled Trials	28
Acromegaly Disease Control Maintained After Switching From Injected Somatostatin Receptor Ligands to Oral Paltusotine	28
Correction to “β-Cell Function and Insulin Sensitivity in Youth With Early Type 1 Diabetes From a 2-Hour 7-Sample OGTT”	28
MeIS: DNA Methylation-Based Immune Response Signatures for Thyroid Nodule Diagnostics	27
Corrigendum to: “The Use of Morning Urinary Gonadotropins and Sex Hormones in the Management of Early Puberty in Chinese Girls”	27
Fat Mass Has Negative Effects on Bone, Especially in Men: A Cross-sectional Analysis of NHANES 2011-2018	27
The Contribution of Deleterious Rare Alleles in ENPP1 and Osteomalacia Causative Genes to Atypical Femoral Fracture	27
Correction to: “Effect of Waiting Time for Radioactive Iodine Therapy on Outcome in N1 Stage Papillary Thyroid Cancer”	27
At any Level of Adiposity, Relatively Elevated Leptin Concentrations Are Associated With Decreased Insulin Sensitivity	27
Endocrine Responses to Triptorelin in Healthy Women, Women With Polycystic Ovary Syndrome, and Women With Hypothalamic Amenorrhea	27
It's Not Just About the Hot Flashes: Menopausal Hormone Changes and Disrupted Sleep	27
Inhibiting Soluble Epoxide Hydrolase Suppresses NF-κB p65 Signaling and Reduces CXCL10 Expression as a Potential Therapeutic Target in Hashimoto's Thyroiditis	27
Reproductive Health in First-degree Relatives of Patients With Polycystic Ovary Syndrome: A Review and Meta-analysis	27
Letter to the Editor From Sävendahl et al.: “Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial”	26
Correction to “Gut Microbiota Composition and Functionality Are Associated With REM Sleep Duration and Continuous Glucose Levels”	26
Understanding Epigenetic Factors on Adiponectin	26
Large-for-Gestational-Age, Leptin, and Adiponectin in Infancy	26
Impaired Metabolic Health and Low Cardiorespiratory Fitness Independently Associate With Subclinical Atherosclerosis in Obesity	26
GH Treatment in Children of Normal Height	26
Letter to the Editor from Han and Xu: “Association Between DPP4 Inhibitor Use and the Incidence of Cirrhosis, ESRD, and Some Cancers in Patients With Diabetes”	26
Association of Mixed Use of Electronic and Conventional Cigarettes and Exposure to Secondhand Smoke With Prediabetes	26
Response to Letter to the Editor From Xu and Yang: “Laser Ablation Versus Radiofrequency Ablation for Thyroid Nodules: 12-Month Results of a Randomized Trial (LARA II Study)”	26
New Horizons: the value of UK Biobank to research on endocrine and metabolic disorders	26
The Beauty of Age-dependent Standardization in Pediatric Endocrine Research and Practice	26
The Association of Female and Male Preconception Dyslipidemia With Live Birth in Couples Seeking Fertility Treatment	26
Correction to: “Increased Risk of Thyroid Eye Disease Following Covid-19 Vaccination”	26
New Hope for a Tumor-Directed Therapy for Cushing Disease	26
Diabetes Duration and the Reverse Impact Between Cholesterol Levels and Risk Among Individuals With Type 2 Diabetes	26
Maternal Thyroid Function: Does It Have a Role in Fetal Programming and Later Offspring Growth?	26
Reproducibility and Refinement of Urinary LH in the Screening of Progressive Puberty in Girls	26
Development of a New Model of Insulin Sensitivity in Patients With Type 2 Diabetes and Association With Mortality	25
Skewness in Body fat Distribution Pattern Links to Specific Cardiometabolic Disease Risk Profiles	25
Endocrine Autoantibodies Determine Immune Checkpoint Inhibitor-induced Endocrinopathy: A Prospective Study	25
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline	25
Somatic Activating ESR1 Mutation in an Aggressive Prolactinoma	25
Intrafollicular Concentrations of the Oocyte-secreted Factors GDF9 and BMP15 Vary Inversely in Polycystic Ovaries	25
Relationship Between Time in Range, Glycemic Variability, HbA1c, and Complications in Adults With Type 1 Diabetes Mellitus	25
Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in France	25
Altered Static and Dynamic Brain Functional Topological Organization in Patients With Dysthyroid Optic Neuropathy	25
Letter to the Editor From Watts and Leslie: Comparisons Between Different Antiosteoporosis Medications on Postfracture Mortality: A Population-based Study	25
Serum Concentrations of Inhibin B in Healthy Females and Males Throughout Life	25
Permanent vs Transient Congenital Hypothyroidism in Chinese Children: Physical Growth and Predictive Nomogram	25
Basal Hyperglycemia Contributes More Than 50% to Time in Range in Pregnant Women With Type 1 Diabetes	25
Molecular Profiling of Low-Risk Papillary Thyroid Carcinoma (mPTC) on Active Surveillance	25
Alteration of Bone Microarchitecture in Hereditary Distal RTA Patients With SLC4A1 Gene Mutation: Assessed by HR-pQCT	25
Correction to: Temporal Trends in Outcomes in Patients with Adrenocortical Carcinoma: A Multidisciplinary Referral Center Experience	25
Another Kid on the Block: Long-acting FGF21 Analogue to Treat Dyslipidemia and Fatty Liver	25
Human GH Use By Athletes With Short Stature Without GH Deficiency: Therapeutic Use Exemptions	24
Beyond Malignancy Risk Stratification: FNAC Report Anticipates Thyroid Cancer Staging. Insights From Recent Studies	24
Long-Term Glycemic Variability Predicts Adverse Outcomes in Diabetic Heart Failure With Preserved Ejection Fraction	24
Adipose Tissue Dysfunction in Polycystic Ovary Syndrome	24
Letter to the Editor From de Zegher and Ibáñez: “Rare Variation in LMNA Underlies Polycystic Ovary Syndrome Pathogenesis in 2 Independent Cohorts”	24
Phthalates and Incident Diabetes in Midlife Women: The Study of Women's Health Across the Nation (SWAN)	24
Approach to the Patient with Achondroplasia—New Considerations for Diagnosis, Management, and Treatment	24
Prediagnostic Vitamin D Status and Colorectal Cancer Survival by Vitamin D Binding Protein Isoforms in US Cohorts	24
SHBG, Bone Mineral Density, and Physical Function Among Injection Drug Users With and Without HIV and HCV	24
Safety, Growth, and Development After Dapagliflozin or Saxagliptin in Children With Type 2 Diabetes (T2NOW Follow-Up)	24
Neuropathic-like Pain in Fibrous Dysplasia/McCune-Albright Syndrome	24
Adrenal Venous Sampling Via an Antecubital Approach in Primary Aldosteronism: A Multicenter Study	24
Progressive 11β-Hydroxysteroid Dehydrogenase Type 2 Insufficiency as Kidney Function Declines	24
Analysis of Delayed Surgery and Clinical Outcomes in Intermediate- and High-risk Papillary Thyroid Cancer	24
Cardiometabolic Risk Assessment in Transgender Individuals—Differential Effect of Sex Hormones and Sex Chromosomes	24
Glycemic Management Around Postprandial Exercise in People With Type 1 Diabetes: Challenge Accepted	24
Hyperglycemia Suppresses Lactate Clearance During Exercise in Type 1 Diabetes	24
Approach to the Pediatric Patient: Central Diabetes Insipidus	24
A Nested Case–Control Study of Adverse Outcomes in Children With Diabetic Ketoacidosis	23
Machine Learning–Based Biomarker Identification for Early Diagnosis of Metabolic Dysfunction–Associated Steatotic Liver Disease	23
The Association Between Pregnancy Complications and Long-term Maternal Cardiometabolic Health in the MIREC Cohort Study	23
Approach to the Patient With Parathyroid Carcinoma	23
Comparison of Different Diagnostic Criteria of 68Ga-Pentixafor PET/CT for the Classification of Primary Aldosteronism	23
Skeletal Effects of Sleeve Gastrectomy, by Sex and Menopausal Status and Compared to Roux-En-Y Gastric Bypass Surgery	23
Role of Sex Hormones in Mediating Adiposity Changes From Weight Loss in People With Type 2 Diabetes: Look AHEAD Sex Hormone Study	23
Machine Learning–Based Survival Prediction Tool for Adrenocortical Carcinoma	23
New Concepts in the Pathogenesis of Cystic Fibrosis–Related Diabetes	23
Comparison of Efficacy of Romosozumab With Denosumab and Risedronate in Patients Newly Initiating Glucocorticoid Therapy	23
Effect of Oral Bisphosphonate Drug Holiday on Mortality Following Hip Fracture	23
A Possible New Biomarker for T1D? : RNA Splicing in Circulating Blood	23
Impact of Setmelanotide on Metabolic Syndrome Risk in Patients With Bardet-Biedl Syndrome	23
Metabolic Phenotype of Stage 1 and Stage 2 Type 1 Diabetes Using Modeling of β Cell Function	23
Epicardial and Pericardial Adiposity Without Myocardial Steatosis in Cushing Syndrome	23
Associations of Homocysteine Metabolism With the Risk of Spinal Osteoarthritis Progression in Postmenopausal Women	23